30 day mortality and eosinopenia in patients with pneumonia

C. Echevarria, T. Hartley, T. Nagarajan, H. Tedd, J. Steer, G. J. Gibson, S. C. Bourke (North Shields, Newcastle, United Kingdom)

Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Session: Different interesting issues in respiratory infections: 1
Session type: Thematic Poster Session
Number: 2550
Disease area: Respiratory infections

Congress or journal article abstract

Abstract

IntroductionBlood eosinophil count is an independent predictor of mortality in patients: with bacteraemia; requiring intensive care; and with acute exacerbations of COPD (AECOPD). In AECOPD eosinopenia may be related to steroid use prior to admission. We describe eosinopenia and mortality in patients with pneumonia and no chronic lung disease or maintenance steroid use.Methods198 patients, mean (SD) age 74 (16) years, were identified and data for mortality, eosinopenia (<0.05x10^9/l) and CURB-65 score (Confusion, Urea >7 mmol/l, Respiratory rate >30/min, low systolic (<90 mm Hg) or diastolic (<60 mm Hg) Blood pressure), age >65 years) were collected. Odds ratios (OR) for death at 30 days were calculated.Results
 30 day mortality
 DeadTotal% deadOR (95% CI)
Confusion score 1388743.74.3 (2.2-8.4)
Confusion score 01711115.3 
Urea score 14712537.64.9 (2.2-11.1)
Urea score 087311.0 
Resp. Rate score 1153839.52.0 (0.9-4.1)
Resp. Rate score 04016025.0 
BP score 1174835.41.6 (0.8-3.3)
BP score 03815125.2 
Age score 15315035.312.6 (2.9-53.9)
Age score 02484.2 
Eosinopenia4112333.32.2 (1.1-4.3)
No eosinopenia147518.7 

A higher proportion of patients with eosinopenia had a raised CRP (>50mg/l) compared with those without eosinopenia (81.3% vs. 62.7% p<0.05).DiscussionBlood eosinopenia <0.05x10^9/l was a strong predictor of 30 day mortality in this cohort with pneumonia, and no chronic respiratory disease. This association cannot be ascribed to steroid use. Eosinopenia may be a marker of severe sepsis and consequent mortality risk (Shaaban et al 2010; Abidi et al 2008), however the association between eosinopenia and CRP >50mg/l was weak.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Echevarria, T. Hartley, T. Nagarajan, H. Tedd, J. Steer, G. J. Gibson, S. C. Bourke (North Shields, Newcastle, United Kingdom). 30 day mortality and eosinopenia in patients with pneumonia. Eur Respir J 2014; 44: Suppl. 58, 2550

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic factors of 30 day mortality in HIV infected patients with community-acquired pneumonia
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014


The neutrophil/lymphocyte ratio in predicting outcome for hospitalized patients with community-acquired pneumonia
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014

Delirium symptoms during hospitalization predict long-term mortality in patients with severe pneumonia
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014

Risk factors for mortality in severe pneumonia patients followed in ICU
Source: International Congress 2015 – Acute critical care: novelties in critical care
Year: 2015

In-hospital mortality risk assessment in patients with community acquired pneumonia
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


Physical deterioration during hospitalization in patients with community-acquired pneumonia
Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions
Year: 2015


Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016


Effect of smoking on prognosis and mortality in patients hospitalized due to community acquired pneumonia
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014

Physiological score SIPF (shock index and hypoxemia) is an accurate predictor of ICU admission in community-acquired pneumonia
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014



Features of pneumonia diagnostics in burn trauma patients
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014



Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


The prevalence of cardiac diseases in patients with community-acquired pneumonia
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014

Cavitary bacterial lung infections – Predictive factors and outcomes
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014


Does previous warfarin treatment effect complications and outcome in hospitalised patients with community-acquired pneumonia?
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


The impact of mixed etiology in community acquired pneumonia (CAP)
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014



The outcome of community-acquired pneumonia in patients with COPD, asthma and ILD - a case-control study
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


Respiratory viral infections in community-acquired pneumonia and exacerbation of COPD: One year survey at a Japanese university hospital
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014


The impact of comorbidities on the in-hospital mortality in patients with community-acquired pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Clinical judgement on top of CURB65-score in predicting 30 days clinical outcome in patients with community acquired pneumonia (CAP) admitted to the hospital
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014

Cardiac troponin T in predicting mortality after hospitalisation for community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies
Year: 2016